Showing 1171-1180 of 2820 results for "".
The Minimal Clinically Important Difference and Its Use in Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/the-minimal-clinically-important-difference-and-its-use-in-neuromuscular-disorders/35532/The minimal clinically important difference facilitates the determination of clinically important and relevant outcome measures in clinical trials and clinical applications and is a promising alternative to statistical significance.Posttraumatic Headache: A Comprehensive Approach
https://practicalneurology.com/diseases-diagnoses/headache-pain/posttraumatic-headache-a-comprehensive-approach/32130/A multimodal, comprehensive, individualized approach to the treatment of posttraumatic headache is essential to optimize outcomes.Return to School, Work, and Sport after Sport-Related Concussion
https://practicalneurology.com/diseases-diagnoses/tbi/return-to-school-work-and-sport-after-sport-related-concussion/31990/Timely, individualized management of SRC can facilitate rapid return to activities, taking into consideration the student-athlete’s clinical presentation, medical conditions, recovery trajectory, and psychological readiness.Practical Recommendations for Monitoring Response to Amyloid-Targeting Treatments for Early Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/practical-recommendations-for-monitoring-response-to-amyloid-targeting-treatments-for-early-alzheimer-disease/36189/The authors present practical recommendations for using cognitive assessments and amyloid PET scanning to monitor response to amyloid-targeting treatments in clinical practice.Neurologic Complications of Tick-Borne Diseases
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neurologic-complications-of-tick-borne-diseases/32152/As the incidence of tick-borne diseases increases, neurologists must recognize and treat their neurologic manifestations.Novel Lipid-Lowering Agents and Stroke Prevention:
New Tools, New Targetshttps://practicalneurology.com/diseases-diagnoses/stroke/novel-lipid-lowering-agents-and-stroke-preventionbrnew-tools-new-targets/32074/Established and novel lipid-lowering agents offer increasing opportunities to achieve effective primary and secondary stroke prevention.Viral Infections of the Central Nervous System: An Update on Herpes Simplex Virus, Varicella-Zoster Virus, and Enterovirus D68
https://practicalneurology.com/diseases-diagnoses/imaging-testing/viral-infections-of-the-central-nervous-system-an-update-on-herpes-simplex-virus-varicella-zoster-virus-and-enterovirus-d68/32151/Recent developments have improved our understanding of herpes simplex virus, varicella-zoster virus, and enterovirus D68 central nervous system infections.Spinal Muscular Atrophy is Now a Treatable Genetic Condition
https://practicalneurology.com/diseases-diagnoses/neuromuscular/spinal-muscular-atrophy-is-now-a-treatable-genetic-condition/32025/Multiple therapy options are available for the treatment of people with spinal muscular atrophy, a genetic disorder presenting with a wide range of symptoms and severity.Hyperglycemia Management
https://practicalneurology.com/diseases-diagnoses/stroke/hyperglycemia-management/31861/The role of hyperglycemia management after ischemic stroke remains elusive.The Effects of Climate Change on Emerging Infections and the Global Landscape of Neuroinfectious Disease
https://practicalneurology.com/diseases-diagnoses/imaging-testing/the-effects-of-climate-change-on-emerging-infections-and-the-global-landscape-of-neuroinfectious-disease/32155/Climate change has direct and indirect effects that have altered the landscape of neuroinfectious disease and will continue to do so.